ALK licenses rights to adrenaline nasal spray, neffy from ARS Pharma for emergency treatment of allergic reactions: Hørsholm, Denmark Tuesday, November 12, 2024, 12:00 Hrs [IST] ...
Request To Download Free Sample of This Strategic Report @- The Global Allergy Diagnostics Market is on the brink of transformative growth, poised to exceed USD 8.6 billion by 2026, according to the ...
In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.